Clinical Trials Sponsored by Mei Han

Total 11974 results

LUN WEI LIU
Chi Mei Medical Hospital

Completed

Effects of Recruitment Maneuvers in Early Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) Patients

Acute Respiratory Distress Syndrome | Lung Injury, Acute

Taiwan
Mei Han

Not yet recruiting

Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule

Primary Biliary Cholangitis
Mei Han

Not yet recruiting

Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases

Neurodegenerative Diseases
Mei Han

Not yet recruiting

Randomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases

Neurodegenerative Diseases
Mei Han

Not yet recruiting

Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Diarrhea-Predominant Irritable Bowel Syndrome
Shu Mei Kato

Recruiting

Study of Personalized Cancer Therapy to Determine Response and Toxicity (UCSD_PREDICT)

Cancer

United States
MEI Pharma, Inc.

Terminated

Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)

United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
MEI Pharma, Inc.

Recruiting

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)

United States
MEI Pharma, Inc.

Active, not recruiting

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Colorectal Cancer

United States
MEI Pharma, Inc.

Completed

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer (OVATURE)

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer

United States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
MEI Pharma, Inc.

Completed

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States, Australia
MEI Pharma, Inc.

Terminated

A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's Lymphoma

United States, Switzerland
MEI Pharma, Inc.

Completed

A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer

Prostate Cancer

United States
Wei Hao

Completed

An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Wei Hao

Completed

A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis

Methamphetamine Dependence

China
Wei Hao

Terminated

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Wei Hao

Terminated

A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis

Methamphetamine Dependence

China
Mei Gao

Not yet recruiting

Factors Related to the Progression of Non-target Coronary Lesions

Coronary Stenosis
Mei Zhang

Active, not recruiting

Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram

Breast Cancer

China
Chi Mei Medical Hospital

Active, not recruiting

Evaluation of Treatment Effect of Minimally Invasive Spinal Fusion Surgery

Spinal Fusion
Mei Zhang

Recruiting

Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy

Breast Cancer

China
Chi Mei Medical Hospital

Not yet recruiting

Exercises on CIPN, Fatigue, and Quality of Life in Colon Cancer Patients Receiving Chemotherapy

Experimental Study Designs
Chi Mei Medical Hospital

Completed

Effect of Stellate Ganglion Block on Meniere's Disease

Vertigo | Meniere Disease

Taiwan
Chi Mei Medical Hospital

Completed

Effect of Airway Integrated Nasal Packing With Different Material

Postoperative Respiratory Complications | Pain, Postoperative.

Taiwan
Fondazione IRCCS San Gerardo dei Tintori

Recruiting

USCOM Parameters in Preterm Infants: Reference Ranges

Very Low Birth Weight Infant | Very Preterm Maturity of Infant

Italy
Dan Nemet, MD

Completed

Specially Designed Eating Plates Effects on Food Intake in Normal Weight and Overweight Children

Obesity

Israel
Fondazione IRCCS San Gerardo dei Tintori

Recruiting

Use of a Diary to Assess and Monitor Behavioral and Psychological Symptoms of Dementia ( BPSDiary ) (BPSDiary)

Behavioral and Psychiatric Symptoms of Dementia

Italy
Fondazione IRCCS San Gerardo dei Tintori

Recruiting

Inspiratory Effort at Different Expiratory Cycling and Airway Resistance During Pressure Support Ventilation (CYCLOPES) (CYCLOPES)

Respiratory Failure

Italy
Yong-Mei Cha

Recruiting

His Bundle Pacing in Bradycardia and Heart Failure

Heart Failure | Bradycardia

United States
MEI Pharma, Inc.
Quotient Clinical

Completed

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143

Malignancies

United Kingdom
Chung Mei Biopharma Co., Ltd

Not yet recruiting

Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Advanced Melanoma
Mei changlin

Unknown

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control (RAFALE)

Hypertension | Autosomal Dominant Polycystic Kidney Disease

China
Maria Wei

Completed

Patient Preference for Biopsy Notification

Elevated Risk for Melanoma

United States
ACT Genomics
Chi Mei Medical Hospital

Unknown

Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens

Sequence Analysis

Taiwan
MEI Pharma, Inc.
Kyowa Kirin, Inc.

Terminated

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)

United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
MEI Pharma, Inc.
Kyowa Kirin, Inc.

Withdrawn

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL (CORAL)

CLL

United States
Van Hanh General Hospital

Unknown

BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients (T2DM)

Type 2 Diabetes Mellitus

Vietnam
University of California, San Francisco
MRI Interventions, Inc.

Completed

Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes (iMRI)

Parkinson's Disease | Dystonia

United States
Lei Lei, MD

Recruiting

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. (ADHD)

Attention Deficit Disorder With Hyperactivity | Executive Function Disorder

China
Shu-Mei Chen

Completed

Elastic Band Resistance Exercise on Glycated Haemoglobin and Muscle Strength, Balance, and Physical Function in Patients With Comorbid Type 2 Diabetes Mellitus and Knee Osteoarthritis

Elastic Band Resistance Exercise With Comorbid Type 2 Diabetes Mellitus and Knee Osteoarthritis

Taiwan
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Completed

Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors (ME-344-001)

Solid Tumors

United States
Mei-fang Huang

Unknown

Effectiveness of Health Management of Glycemic Control and Physical Activity in Type 2 Diabetes Mellitus Using Smartphone Application

To Investigate the Effectiveness of Health Management of Glycemic Control and Physical Activity in Type 2 Diabetes Mellitus Using Smartphone Application

Taiwan
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Terminated

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

Solid Tumors

United States, United Kingdom
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Completed

Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors

Solid Tumors

United States
Mei-Yun Chang

Completed

A Comparison of Optimal PEEP Determination Guided by EIT and G5 Device in Moderate and Severe ARDS Patients

Acute Respiratory Distress Syndrome

Taiwan
University of California, San Diego
National Eye Institute (NEI)

Recruiting

Diagnostic Innovations in Glaucoma Study (DIGS)

Primary Open Angle Glaucoma | Myopia

United States
University of California, San Francisco
National Eye Institute (NEI)

Withdrawn

Nepal Elimination of Trachoma Study (NETS)

Trachoma

Nepal
University of California, San Diego
National Eye Institute (NEI)

Enrolling by invitation

African Descent and Glaucoma Evaluation Study (ADAGES)

Primary Open Angle Glaucoma

United States
Meir Medical Center
Tel Hai College; University of Haifa

Unknown

The Effects of Omega-3 Status and Supplementation on Tendon Structure in Competitive Athletes

Inflammation | Tendon Injuries

Israel
MTI University

Recruiting

Effect of Posterior Pelvic Tilt on Balance and Sensory Integration in Patients With Non-specific Low Back Pain

Orthopedic Disorder of Spine | Biochemical Lesions Lumbar Region | Back Disorder

Egypt

Clinical Trials Sponsored by Mei Han

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations